Mood Disorders News

Prescription opioid dispensing decreased for patients with schizophrenia, as well as those with bipolar disorder, between 2015 and 2019, according to study results presented at NEI Congress.

Latuda use was associated with statistically significant improvements on individual quality-of-life items compared with placebo among patients with bipolar depression.

Adolescent depression appeared linked to lower sexual functioning and selective serotonin reuptake inhibitors with impaired orgasm, according to results of a prospective study published in Journal of Clinical Psychiatry.

Older adults frequently used medication to treat sleep difficulties, according to study results presented at Psych Congress.

Simultaneous initiation of benzodiazepine and selective serotonin reuptake inhibitor treatment was somewhat common among young adults with anxiety disorders, according to study results published in Journal of Clinical Psychiatry.

Healio Psychiatry’s five most-viewed stories in October highlight: the mental health effects of sibling bullying, the link between staying up late and suicidal thoughts, and regulatory developments.

Vision impairment may increase risk for future depressive symptoms among women during midlife, according to study results published in Menopause: The Journal of The North American Menopause Society.

Several factors, including age at onset during adolescence, can differentiate the future course of adolescent depression, according to results of a longitudinal, population-based study published in The Lancet Psychiatry.

Prescriptions for Z-hypnotics, selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, and benzodiazepines have increased during the COVID-19 pandemic.

Increased white blood cell count appeared linked to increased depression polygenic scores, with a potential bidirectional association, according to results of a genetic association study published in JAMA Psychiatry.